SFX by Ex Libris Inc.

Title:	How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse
Source:	Human Molecular Genetics [0964-6906] Godfrey, C yr:2015

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Rosenberg, Amy S S. "Immune-mediated pathology in Duchenne muscular dystrophy." Science translational medicine 7.299 (2015): 299-299.
description	2.	Xu, D. "MicroRNA-10a Regulation of Proinflammatory Mediators: An Important Component of Untreated Juvenile Dermatomyositis." Journal of rheumatology 43.1 (2015): 161-168.
description	3.	Straub, V. "Recent advances in the management of Duchenne muscular dystrophy." Archives of disease in childhood 100.12 (2015): 1173-1177.
description	4.	van Westering, Tirsa L E L. "Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy." Molecules 20.5 (2015): 8823-8855.
description	5.	Paczek, L. "Myogenic stem cells." Folia Histochemica et Cytobiologica 46.4 (2008): 401-12.
description	6.	Yiu, Andrew M. "Duchenne muscular dystrophy." Journal of paediatrics and child health 51.8 (2015): 759-64.
description	7.	Korinthenberg, R. "A new era in the management of Duchenne muscular dystrophy." Developmental medicine and child neurology 61.3 (2019): 292-297.
description	8.	Jette, N. "A Systematic Review and Meta-analysis on the Epidemiology of Duchenne and Becker muscular dystrophy." Neuromuscular disorders In press.In press (2014): 482-91.
description	9.	Fairclough, Rebecca J. "Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches." Nature reviews. Genetics 14.6 (2013): 373-378.
description	10.	Qu, Yanlin a. "A POMC-originated circuit regulates stress-induced hypophagia, depression, and anhedonia." Molecular Psychiatry 25.5 (2019): 1006-1021.
description	11.	WEIN, N. "Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy." The Pediatric clinics of North America 62.3 (2015): 723-742.
description	12.	Fujak, A. "[Current care strategies for Duchenne muscular dystrophy.]." Der Orthopäde 43.7 (2014): 636-42.
description	13.	Skrzynia, C. "Genetics and Heart Failure: A Concise Guide for the Clinician." Current cardiology reviews 11.1 (2013): 10-7.
description	14.	Chan, S. "The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy." Experimental physiology 96.6 (2011): 564-71.
description	15.	Heemskerk, H. "Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy." Annals of the New York Academy of Sciences 1175.01 (2009): 71-79.
description	16.	Boonen, K. "The Muscle Stem Cell Niche: Regulation of Satellite Cells During Regeneration." Tissue Engineering Part B: Reviews 14.4 (2008): 419-431.
description	17.	Smith, C. "The Inflammatory Response to Skeletal Muscle Injury: Illuminating Complexities." Sports medicine 38.11 (2008): 947-969.
description	18.	Manzur AY, A Y. "Update on the management of Duchenne muscular dystrophy." Archives of disease in childhood 93.11 (2008): 986-990.
description	19.	Buckingham, Margaret, M. "Skeletal muscle stem cells." Current opinion in genetics & development 18.4 (2008): 330-336.
description	20.	Nassiri, Seyed Mahdi M. "The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction." Journal of biomedical science 14.6 (2007): 745-755.